VERAPAMIL HYDROCHLORIDE
- Product NDC
- 42291-853
- Requested package NDC
- 42291-853-01
- 11-digit product format
- 422910853
- Labeler code
- 42291
- Product ID
- 42291-853_4875cced-75af-ed7f-e063-6294a90addfa
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- VERAPAMIL HYDROCHLORIDE
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- AvKARE
- Application
- ANDA071881
- Marketing category
- ANDA
- Marketing start
- 2020-04-13
- Substance
- VERAPAMIL HYDROCHLORIDE
- Active strength
- 40 mg/1
- Pharmacologic classes
- Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A071881-001 | VERAPAMIL HYDROCHLORIDE | VERAPAMIL HYDROCHLORIDE | 120MG | TABLET / ORAL | AB | RS | 1988-04-05 |
| A071881-002 | VERAPAMIL HYDROCHLORIDE | VERAPAMIL HYDROCHLORIDE | 40MG | TABLET / ORAL | AB | 2015-10-14 | |
| A071881-003 | VERAPAMIL HYDROCHLORIDE | VERAPAMIL HYDROCHLORIDE | 80MG | TABLET / ORAL | AB | 1988-04-05 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A071881-001 | AB |
| A071881-002 | AB |
| A071881-003 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A071881-001 | VERAPAMIL HYDROCHLORIDE | 120MG | TABLET / ORAL | AB | RS | 1988-04-05 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A071881-002 | VERAPAMIL HYDROCHLORIDE | 40MG | TABLET / ORAL | AB | 2015-10-14 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A071881-003 | VERAPAMIL HYDROCHLORIDE | 80MG | TABLET / ORAL | AB | 1988-04-05 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A071881-001 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A071881-002 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A071881-003 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| VERAPAMIL HYDROCHLORIDE | VERAPAMIL HYDROCHLORIDE | AvKARE | a32f346e-71cf-cc11-e053-2a95a90ae88c | 2026-01-15 | Warnings, Adverse reactions | 071881 ANDA071881 42291-853-01 42291-853 42291085301 |
| VERAPAMIL HYDROCHLORIDE | VERAPAMIL HYDROCHLORIDE | Northwind Health Company, LLC | f2f059a1-0cf9-a5d6-e053-2a95a90a3dab | 2026-01-01 | Warnings, Adverse reactions | 071881 ANDA071881 |
| VERAPAMIL HYDROCHLORIDE | VERAPAMIL HYDROCHLORIDE | Chartwell RX, LLC | ebc9a09a-7b5f-4df6-ace7-31185d469b28 | 2025-12-10 | Warnings, Adverse reactions | 071881 ANDA071881 |
| VERAPAMIL HYDROCHLORIDE | VERAPAMIL HYDROCHLORIDE | Preferred Pharmaceuticals Inc. | c7a54ee0-80c0-4c7e-a6a3-cb60142f860c | 2025-10-02 | Warnings, Adverse reactions | 071881 ANDA071881 |
| VERAPAMIL HYDROCHLORIDE | VERAPAMIL HYDROCHLORIDE | Golden State Medical Supply, Inc. | 3283bba6-05dd-3766-e063-6394a90ada69 | 2025-04-11 | Warnings, Adverse reactions | 071881 ANDA071881 |
| VERAPAMIL HYDROCHLORIDE | VERAPAMIL HYDROCHLORIDE | NuCare Pharmaceuticals,Inc. | fe0583bf-9986-e01e-e053-6294a90a0b26 | 2025-02-04 | Warnings, Adverse reactions | 071881 ANDA071881 |
| VERAPAMIL HYDROCHLORIDE | VERAPAMIL HYDROCHLORIDE | Bryant Ranch Prepack | 660a83a9-60be-42d5-bc70-fe384e93beaa | 2024-10-24 | Warnings, Adverse reactions | 071881 ANDA071881 |
| VERAPAMIL HYDROCHLORIDE | VERAPAMIL HYDROCHLORIDE | NuCare Pharmaceuticals,Inc. | 7b321aa1-1b53-26d5-e053-2991aa0a1373 | 2024-06-12 | Warnings, Adverse reactions | 071881 ANDA071881 |
| VERAPAMIL HYDROCHLORIDE | VERAPAMIL HYDROCHLORIDE | Bryant Ranch Prepack | d4a6c046-81fe-4b2a-9cb0-adb3f037eec7 | 2024-01-26 | Warnings, Adverse reactions | 071881 ANDA071881 |
| VERAPAMIL HYDROCHLORIDE | VERAPAMIL HYDROCHLORIDE | A-S Medication Solutions | f00c1caf-68b6-40c1-a1fa-72d17d2cf44f | 2023-05-04 | Warnings, Adverse reactions | 071881 ANDA071881 |
| VERAPAMIL HYDROCHLORIDE | VERAPAMIL HYDROCHLORIDE | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | ed1e0c14-3571-43f9-88fc-5a4d2b598263 | 2022-03-12 | Warnings, Adverse reactions | 071881 ANDA071881 |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- VERAPAMIL HYDROCHLORIDE
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| VERAPAMIL HYDROCHLORIDE | 40 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| V3888OEY5R | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| a32f346e-71cf-cc11-e053-2a95a90ae88c | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| ea1f6fc8-bfc2-4421-a2eb-4e87c7c3e3c4 | Product name | 2 | 20230103 |
| 33ad674d-d105-6aa5-02fa-95ae4329b8cd | Product name | 2 | 20180809 |
| 3279bd6d-5b02-e60b-3857-c853a2deb2dd | Product name | 2 | 20170713 |
| 8ebb66e3-d7b3-f1e5-88aa-3369e64bb84a | Product name | 1 | 20140508 |
| 940a1faa-2df8-cc65-be37-1b97984b4ea3 | Product name | 1 | 20140508 |
| d3b67bc2-0e96-e3ec-06a9-90afcc07bf13 | Product name | 1 | 20140508 |
| e2fcd66c-a043-3187-790d-b0342deb1149 | Product name | 1 | 20140508 |
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 42291-853-01 | VERAPAMIL HYDROCHLORIDE | 100 in 1 BOTTLE | TABLET | 100 | 4 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 42291-853-01 | EA - Each | 42291-853 | efe0d46d-5b2c-4efa-aa63-29a4ff39720d | 1 | 2020-05-08 |
DailyMed Dashboard NDC Coverage#
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 897666 | verapamil HCl 120 MG Oral Tablet | PSN | a32f346e-71cf-cc11-e053-2a95a90ae88c | 4 |
| 897722 | verapamil HCl 40 MG Oral Tablet | PSN | a32f346e-71cf-cc11-e053-2a95a90ae88c | 4 |
| 897683 | verapamil HCl 80 MG Oral Tablet | PSN | a32f346e-71cf-cc11-e053-2a95a90ae88c | 4 |
| 897666 | verapamil hydrochloride 120 MG Oral Tablet | SCD | a32f346e-71cf-cc11-e053-2a95a90ae88c | 4 |
| 897722 | verapamil hydrochloride 40 MG Oral Tablet | SCD | a32f346e-71cf-cc11-e053-2a95a90ae88c | 4 |
| 897683 | verapamil hydrochloride 80 MG Oral Tablet | SCD | a32f346e-71cf-cc11-e053-2a95a90ae88c | 4 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 42291-853-01 | 42291085301 | 100 TABLET in 1 BOTTLE (42291-853-01) | 100 tablet | 2020-04-13 | 0000-00-00 | No | No | Current |